GGrantIndex
← Search

Advanced Development of Multivalent Filovirus Vaccines

$4,000,000N01FY2013AINIH

Janessen Vaccines And Prevention, Bv, Leiden

Investigators

Abstract

This contract supports advanced development of a multivalent filovirus (biodefense) vaccine that could address both Ebola and Marburg viruses; support may be provided through early clinical development of the filovirus vaccine candidate.

View original record on NIH RePORTER →